Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.0K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.0K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

764
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
764
Ligand Binding Sites02:40

Ligand Binding Sites

12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

577
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
577
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

232
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
232

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification and characterization of lncRNA-stemness-immune regulatory patterns.

Briefings in bioinformatics·2026
Same author

CFGSCDSA: Predicting circRNA-drug sensitivity associations based on collaborative feature learning and graph structure learning.

PLoS computational biology·2026
Same author

Structure-Aware Heterogeneous Information Fusion Framework for Protein-Ligand Binding Affinity Prediction.

Journal of chemical information and modeling·2025
Same author

A Transformer-Based Deep Learning Approach to Predicting Air Organic Pollutant-Human Protein Interactions.

Environmental science & technology·2025
Same author

Long Noncoding RNA function prediction via multiview cross-contrastive learning combined with multiscale semantic adaptive optimization.

Briefings in bioinformatics·2025
Same author

Cross-RNA transferable sequence representation learning for lncRNA m6A site detection via novel deep domain separation networks.

Briefings in bioinformatics·2025

Related Experiment Video

Updated: Jul 16, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K

DataDTA: a multi-feature and dual-interaction aggregation framework for drug-target binding affinity prediction.

Yan Zhu1, Lingling Zhao1, Naifeng Wen2

  • 1Faculty of Computing, Harbin Institute of Technology, Harbin 150001, China.

Bioinformatics (Oxford, England)
|September 9, 2023
PubMed
Summary

Accurate drug-target binding affinity (DTA) prediction is vital for drug discovery. DataDTA, a novel deep learning method, effectively integrates protein pocket and sequence information with compound features for enhanced DTA prediction.

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

318
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K

Related Experiment Videos

Last Updated: Jul 16, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

318
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Drug discovery

Background:

  • Accurate drug-target binding affinity (DTA) prediction is essential for efficient drug discovery.
  • Existing deep learning methods often use limited information, neglecting effective integration of diverse data types and protein-binding pockets.
  • There is a need for advanced computational methods that leverage comprehensive data for improved DTA prediction.

Purpose of the Study:

  • To develop a novel deep learning-based predictor, DataDTA, for accurate estimation of drug-target binding affinities.
  • To effectively integrate protein sequence, predicted protein-binding pocket descriptors, and compound molecular features (SMILES, algebraic graph features) for DTA prediction.
  • To enhance the prediction accuracy by employing a dual-interaction aggregation neural network strategy for multiscale feature learning.

Main Methods:

  • DataDTA utilizes predicted protein pocket descriptors and protein sequences as input features.
  • Compound information is represented using low-dimensional molecular features and SMILES strings.
  • A dual-interaction aggregation neural network architecture is employed to learn multiscale interaction features between drugs and protein targets.

Main Results:

  • DataDTA demonstrated reliable performance in estimating drug-target binding affinities.
  • The model achieved a concordance index (CI) of 0.806 and a Pearson correlation coefficient (R) of 0.814 on the test dataset.
  • These results indicate superior performance compared to existing state-of-the-art methods.

Conclusions:

  • DataDTA represents a significant advancement in computational methods for DTA prediction.
  • The integration of diverse data sources and a novel neural network strategy leads to improved prediction accuracy.
  • DataDTA has the potential to accelerate the drug discovery process by providing reliable affinity estimations.